Neuroscience

Global Neuroscience Market to Reach US$50.9 Billion by 2030

The global market for Neuroscience estimated at US$40.5 Billion in the year 2024, is expected to reach US$50.9 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$29.9 Billion by the end of the analysis period. Growth in the Software segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$11.0 Billion While China is Forecast to Grow at 3.8% CAGR

The Neuroscience market in the U.S. is estimated at US$11.0 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$8.2 Billion by the year 2030 trailing a CAGR of 3.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Neuroscience Market - Key Trends & Drivers Summarized

What Is Neuroscience and Why Is It Critical for Modern Medicine?
Neuroscience is the scientific study of the nervous system, encompassing a broad range of research areas, from molecular biology and genetics to behavior and cognitive functions. This field is critical for understanding how the brain and nervous system work, and it plays a pivotal role in diagnosing, treating, and preventing neurological disorders like Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and epilepsy. Neuroscience not only investigates normal brain functions but also explores pathological conditions, helping to develop therapies that improve patient outcomes and advance knowledge of the human brain.

The importance of neuroscience is growing as neurological and psychiatric disorders become more prevalent globally, particularly in aging populations. Breakthroughs in neuroscience research have led to the development of new treatments and technologies, such as neuroprosthetics, brain-machine interfaces, and deep brain stimulation (DBS). The integration of AI, neuroimaging, and big data analytics in neuroscience is further accelerating discoveries, making it one of the most promising fields in modern medicine for addressing mental health and neurological diseases.

How Is Neuroscience Research Evolving?
Neuroscience research is evolving rapidly, driven by technological advancements and the integration of interdisciplinary approaches. One of the major trends shaping the field is the use of neuroimaging techniques, such as functional magnetic resonance imaging (fMRI) and positron emission tomography (PET), which allow researchers to observe brain activity in real-time. These technologies have become essential tools in understanding the neural basis of cognitive functions like memory, perception, and decision-making, as well as in diagnosing and tracking the progression of neurological diseases.

Another significant development in neuroscience is the application of artificial intelligence (AI) and machine learning to analyze complex brain data. AI algorithms are increasingly being used to identify patterns in large datasets, helping scientists make sense of the brain’s intricate wiring and uncover new insights into brain disorders. In parallel, advances in optogenetics—a technique that uses light to control neurons—are enabling more precise control over brain circuits, offering new possibilities for treating conditions such as depression, addiction, and schizophrenia. The growing use of stem cell research and gene editing technologies, such as CRISPR, is also transforming neuroscience, allowing for deeper exploration into neurodegenerative diseases at the cellular level.

Which Areas of Healthcare Are Driving Neuroscience Research?
Neuroscience research is heavily influenced by the healthcare industry’s need to address a wide range of neurological conditions. Neurodegenerative diseases such as Alzheimer’s and Parkinson’s are significant drivers of neuroscience research, as these disorders affect millions worldwide and currently have no cure. Research in these areas focuses on understanding the underlying causes of these diseases, identifying biomarkers for early diagnosis, and developing therapies to slow or prevent disease progression. Psychiatric disorders, including depression, anxiety, and bipolar disorder, are also major areas of focus, with neuroscience research aiming to better understand the brain’s role in mental health and develop more effective treatments.

The field of neurology is driving advancements in stroke treatment and recovery, with neuroscience research playing a critical role in improving outcomes for stroke patients. Additionally, neuroscience is making significant contributions to rehabilitation techniques for patients with traumatic brain injuries, spinal cord injuries, and neurological conditions like multiple sclerosis. Pediatric neurology, particularly in areas like autism spectrum disorders and epilepsy, is another crucial area where neuroscience is driving innovation and improving patient care through early diagnosis and intervention.

What Are the Key Growth Drivers in the Neuroscience Market?
The growth in the neuroscience market is driven by several factors, most notably the rising prevalence of neurological and psychiatric disorders, particularly in aging populations. As the incidence of diseases such as Alzheimer’s and Parkinson’s continues to increase, there is a growing need for advanced research, diagnostics, and treatments in the neuroscience field. Another key driver is the rapid pace of technological advancements in neuroimaging, genomics, and bioinformatics, which are enabling researchers to conduct more detailed studies of the brain and nervous system.

The integration of AI and machine learning in neuroscience research is also a significant growth driver, as these technologies are enhancing the ability to analyze complex brain data, uncover new patterns, and accelerate drug discovery. Moreover, increasing government and private sector investments in neuroscience research, along with a focus on mental health and neurological disease research initiatives, are fueling the expansion of this market. Finally, the growing collaboration between academia, industry, and healthcare providers is driving innovation in neuroscience, leading to more effective therapies and better patient outcomes.

SCOPE OF STUDY:

The report analyzes the Neuroscience market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Component (Instruments, Software, Services); Technology (Whole Brain Imaging, Neuro-Microscopy, Electrophysiology, Neuro-Functional Visualization, Neuro-Proteomic Analysis, Other Technologies); End-Use (Diagnostic Laboratories, Hospitals, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

• Alpha Omega Co. USA Inc.
• Axion BioSystems Inc.
• Biobserve GmbH
• Blackrock Microsystems LLC
• Bruker Corporation
• Doric Lenses Inc
• Femtonics Ltd.
• GE Healthcare
• Intan Technologies, LLC.
• Kendall Research Systems, LLC (KRS)
• Laserglow Technologies
• LaVision BioTec GmbH
• Med Associates, Inc.
• Mediso Medical Imaging Systems
• Mightex Systems
• Multi Channel Systems MCS GmbH
• Neuralynx, Inc.
• NeuroNexus
• Newport Corporation
• Noldus Information Technology
• Phoenix Research Labs
• Plexon Inc.
• Scientifica Ltd
• Siemens Healthineers
• Sutter Instrument
• Thomas RECORDING GmbH
• Trifoil Imaging, Inc.
• Tucker Davis Technologies Inc. (TDT)
• Vium, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs CBob geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.